Literature DB >> 8342998

Developmental expression of the neurotensin gene in the rat liver.

B M Evers1, S Rajaraman, D H Chung, C M Townsend, X Wang, K Graves, J C Thompson.   

Abstract

OBJECTIVE: This study determined whether the neurotensin gene is expressed during early development of the liver. SUMMARY BACKGROUND DATA: Neurotensin (NT), a gut tridecapeptide localized mainly to the distal small bowel and brain of adults, is an important hormone regulating gut motility, secretion and mucosal growth. Expression of NT peptide and the gene is found in fibrolamellar hepatocarcinomas, a variant of hepatocellular carcinoma, but not in the normal adult liver.
METHODS: Northern and in situ hybridization techniques were used to determine expression of the neurotensin gene (NT/N) in the normal developing liver.
RESULTS: NT/N is expressed in the fetal and early postnatal rat liver, but expression is repressed in the liver of the adult. In situ hybridization confirms the authors' Northern data and demonstrates a random distribution of NT/N expression in the fetal and 3-day postnatal liver.
CONCLUSIONS: The authors conclude from this study that NT/N is expressed during early development of the rat liver with subsequent repression in the adult. NT/N may be reexpressed with malignant transformation of the liver.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342998      PMCID: PMC1242928          DOI: 10.1097/00000658-199308000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  32 in total

Review 1.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Authors:  P J Mitchell; R Tjian
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

2.  Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer.

Authors:  M Tanaka; H Sasaki; I Kino; T Sugimura; M Terada
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

3.  Characterization of neurotensin(6-13) from an hepatic fibrolamellar carcinoma.

Authors:  D Read; A Shulkes; R Fernley; R Simpson
Journal:  Peptides       Date:  1991 Jul-Aug       Impact factor: 3.750

4.  p1B15: a cDNA clone of the rat mRNA encoding cyclophilin.

Authors:  P E Danielson; S Forss-Petter; M A Brow; L Calavetta; J Douglass; R J Milner; J G Sutcliffe
Journal:  DNA       Date:  1988-05

5.  Presence of neurotensin and neuromedin-N within a common precursor from a human pancreatic neuroendocrine tumor.

Authors:  R E Carraway; S P Mitra; G E Feurle; W H Hacki
Journal:  J Clin Endocrinol Metab       Date:  1988-06       Impact factor: 5.958

6.  Expression of neurotensin in endocrine tumors.

Authors:  M Kapuscinski; A Shulkes; D Read; K J Hardy
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

7.  Expression of neurotensin messenger RNA in a human carcinoid tumor.

Authors:  B M Evers; J Ishizuka; C M Townsend; S Rajaraman; J C Thompson
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

8.  Posttranscriptional regulation of neurotensin in the gut.

Authors:  B M Evers; R D Beauchamp; J Ishizuka; C M Townsend; T Alam; J Papaconstantinou; J C Thompson
Journal:  Surgery       Date:  1991-08       Impact factor: 3.982

9.  Neurotensin prevents intestinal mucosal hypoplasia in rats fed an elemental diet.

Authors:  B M Evers; M Izukura; C M Townsend; T Uchida; J C Thompson
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

10.  Neurotensin stimulates growth of small intestine in rats.

Authors:  J G Wood; H D Hoang; L J Bussjaeger; T E Solomon
Journal:  Am J Physiol       Date:  1988-12
View more
  3 in total

1.  Characterization of early developmental pattern of expression of neurotensin/neuromedin N gene in foregut and midgut.

Authors:  X M Wang; B M Evers
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

2.  Expression of the neurotensin gene in fetal human liver and fibrolamellar carcinoma.

Authors:  J A Ehrenfried; Z Zhou; J C Thompson; B M Evers
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

Review 3.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.